These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7626224)

  • 1. Protection against Mycoplasma pulmonis infection by genetic vaccination.
    Lai WC; Bennett M; Johnston SA; Barry MA; Pakes SP
    DNA Cell Biol; 1995 Jul; 14(7):643-51. PubMed ID: 7626224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against mycoplasma infection using expression-library immunization.
    Barry MA; Lai WC; Johnston SA
    Nature; 1995 Oct; 377(6550):632-5. PubMed ID: 7566175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of DNA immunization of genetically susceptible mice infected with virulent Mycoplasma pulmonis.
    Lai WC; Pakes SP; Ren K; Lu YS; Bennett M
    J Immunol; 1997 Mar; 158(6):2513-6. PubMed ID: 9058780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive protein antigens of Mycoplasma pulmonis in experimentally infected rats.
    Chang J; Pick JR
    Am J Vet Res; 1986 Sep; 47(9):1901-4. PubMed ID: 3767096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization is a simple method for eliciting an immune response.
    Tang DC; DeVit M; Johnston SA
    Nature; 1992 Mar; 356(6365):152-4. PubMed ID: 1545867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma pulmonis depresses humoral and cell-mediated responses in mice.
    Lai WC; Pakes SP; Owusu I; Wang S
    Lab Anim Sci; 1989 Jan; 39(1):11-5. PubMed ID: 2521910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice against experimental murine mycoplasmosis by a Mycoplasma pulmonis immunogen in lysogenized Escherichia coli.
    Lai WC; Bennett M; Gordon BE; Pakes SP
    Vaccine; 1994 Mar; 12(4):291-8. PubMed ID: 8178549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease.
    Hodge LM; Simecka JW
    J Infect Dis; 2002 Jul; 186(2):290-4. PubMed ID: 12134269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential subunit vaccine against Mycoplasma pulmonis purified by a protective monoclonal antibody.
    Lai WC; Bennett M; Pakes SP; Murphree SS
    Vaccine; 1991 Mar; 9(3):177-84. PubMed ID: 1828319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated and humoral immune response to non-viable Mycoplasma pulmonis in mice enhanced by cross-linked ricin.
    Kishima M; Kuniyasu C; Eguchi M; Yamamoto M; Imamura E
    Vet Microbiol; 1987 Jun; 14(2):145-56. PubMed ID: 3660582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro stimulation of nonimmunized, naturally infected rat spleen cells for the production of Mycoplasma pulmonis-specific monoclonal antibodies.
    Jarvill KJ; Minion FC
    Hybridoma; 1989 Oct; 8(5):545-50. PubMed ID: 2807312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Mycoplasma pulmonis antigens in Escherichia coli.
    Kunita S; Terada E; Ghoda A; Sakurai Y; Suzuki H; Takakura A; Kagiyama N
    Jikken Dobutsu; 1989 Jul; 38(3):207-13. PubMed ID: 2507332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary intratracheal infection of mice with Mycoplasma pulmonis generates IgG1 memory B cells.
    Rose FV; Cebra JJ
    Isr J Med Sci; 1987 May; 23(5):490-5. PubMed ID: 3499421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene.
    Kayes SG; Shaneyfelt RC; Monteiro C; O'Brien JJ
    J Parasitol; 1998 Aug; 84(4):764-70. PubMed ID: 9714208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated and humoral immune responses in mice during experimental infection with Mycoplasma pulmonis.
    Kishima M; Kuniyasu C; Eguchi M
    Lab Anim; 1989 Apr; 23(2):138-42. PubMed ID: 2709792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses elicited by Mycoplasma hyopneumoniae recombinant antigens and DNA constructs with potential for use in vaccination against porcine enzootic pneumonia.
    Virginio VG; Gonchoroski T; Paes JA; Schuck DC; Zaha A; Ferreira HB
    Vaccine; 2014 Oct; 32(44):5832-8. PubMed ID: 25148775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization with the immunodominant antigen P48 of Mycoplasma agalactiae stimulates a mixed adaptive immune response in BALBc mice.
    Chessa B; Pittau M; Puricelli M; Zobba R; Coradduzza E; Dall'ara P; Rosati S; Poli G; Alberti A
    Res Vet Sci; 2009 Jun; 86(3):414-20. PubMed ID: 19007952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice.
    Taylor G; Taylor-Robinson D
    Immunology; 1976 May; 30(5):611-8. PubMed ID: 1278933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes.
    Chen H; Chen G; Zheng H; Guo H
    Chin Med J (Engl); 2003 Oct; 116(10):1561-6. PubMed ID: 14570624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.